Bladder cancer is the ninth most common cancer worldwide and one of the more frequently diagnosed cancers in the United States, with roughly 82,000 new cases estimated in 2023 alone. It affects men far more often than women, and risk climbs sharply with age. While those numbers sound large, your individual risk depends heavily on a few key factors, especially smoking history, sex, and race.
How Many People Get Bladder Cancer Each Year
In the U.S., bladder cancer is diagnosed at a rate of about 15 to 37 new cases per 100,000 men each year, depending on race and ethnicity. For women, those numbers drop to roughly 4 to 9 per 100,000. Non-Hispanic white men have the highest incidence at 37.3 per 100,000, making bladder cancer one of the top ten cancers in this group. Among women, non-Hispanic white women lead at 9.1 per 100,000, followed by non-Hispanic Black women at 6.1.
Globally, bladder cancer ranks as the ninth most common cancer type. It is considerably more prevalent in North America and Europe than in parts of Asia and Africa, largely because of differences in smoking rates and occupational chemical exposures across regions.
Men vs. Women: A Wide Gap
Men are about three to four times more likely to develop bladder cancer than women. This gap holds across every racial and ethnic group. Non-Hispanic white men are diagnosed at a rate of 37.3 per 100,000, while non-Hispanic white women are diagnosed at 9.1 per 100,000. Among non-Hispanic Black Americans, the rates are 19.6 for men and 6.1 for women.
The reasons for this disparity aren’t entirely explained by lifestyle. Men have historically smoked at higher rates, and they’re more likely to work in industries with chemical exposures (manufacturing, trucking, painting). But even after accounting for those factors, biological differences in how the bladder processes carcinogens likely play a role. One important caveat: women are often diagnosed at a later stage, partly because blood in the urine, the most common early symptom, is more likely to be attributed to other causes like urinary tract infections or menstruation before bladder cancer is investigated.
Risk by Race and Ethnicity
White men have by far the highest diagnosis rates, but the picture shifts when you look at outcomes. Non-Hispanic Black men are diagnosed at about half the rate of white men (19.6 vs. 37.3 per 100,000), yet their death rate relative to their incidence is proportionally higher. The death rate for non-Hispanic Black men is 5.1 per 100,000, compared to 7.9 for white men, a narrower gap than the incidence numbers suggest. This pattern points to later-stage diagnoses and disparities in access to timely treatment among Black patients.
Hispanic and Asian/Pacific Islander populations have the lowest incidence rates for both men and women, with Asian/Pacific Islander women having the lowest rate at just 3.6 per 100,000. Their death rates are correspondingly lower, at 0.9 per 100,000 for women and 2.7 for men.
Age Is the Strongest Predictor
Bladder cancer is overwhelmingly a disease of older adults. The median age at diagnosis is 73, and the vast majority of cases occur in people over 55. Diagnoses under age 40 are rare. Risk increases steadily with each decade of life, which is why bladder cancer can seem uncommon in everyday experience even though the total numbers are high. Most of those 82,000 annual cases are concentrated among people in their 60s, 70s, and 80s.
Smoking Is the Biggest Risk Factor
Tobacco use accounts for approximately half of all bladder cancer cases. The chemicals in cigarette smoke are filtered by the kidneys and collect in the bladder, where they sit in contact with the bladder lining for hours at a time. This prolonged exposure damages cells and, over years, can trigger cancerous changes. Current smokers face roughly three times the risk of nonsmokers, and former smokers remain at elevated risk for years after quitting, though the risk does gradually decline.
Occupational exposure to certain industrial chemicals is the second most significant risk factor. Workers in rubber manufacturing, leather processing, textile production, and painting have higher rates. Chronic bladder infections and long-term catheter use also increase risk modestly.
Most Cases Are Caught Early
About 75% of bladder cancers are non-muscle invasive at the time of diagnosis, meaning the cancer is confined to the inner lining of the bladder and hasn’t grown into the deeper muscle wall. This is the most treatable form. The remaining 25% are either muscle-invasive or have already spread beyond the bladder.
The stage at diagnosis makes a dramatic difference in outcomes. The five-year relative survival rate for localized bladder cancer (still contained within the bladder) is 71%. Once cancer has spread to nearby lymph nodes or organs, that drops to 39%. For metastatic bladder cancer that has reached distant parts of the body, the five-year survival rate is just 8%.
These numbers underscore why the most common early symptom, blood in the urine, deserves prompt attention. It is painless in most cases and can come and go, which sometimes leads people to dismiss it. Frequent urination, urgency, and pain during urination are other possible signs, though these overlap with many non-cancerous conditions.
What Happens After Diagnosis
For the 75% of patients with non-muscle invasive disease, treatment typically starts with a procedure to remove visible tumors from the bladder lining through a scope inserted through the urethra. There’s no external incision. Many patients then receive a series of treatments delivered directly into the bladder to reduce the chance of recurrence. This is important because non-muscle invasive bladder cancer has a high recurrence rate, and regular monitoring with cystoscopy (a camera examination of the bladder) continues for years afterward.
For muscle-invasive cases, treatment is more intensive and often involves surgical removal of the bladder, sometimes combined with chemotherapy or immunotherapy. Recovery from bladder removal is significant, and patients need an alternative way to store or pass urine, either through a surgically created internal reservoir or an external collection system. The choice depends on overall health and the extent of the cancer.
Putting Your Personal Risk in Context
If you’re a man under 55 who has never smoked, your near-term risk of bladder cancer is quite low. If you’re a man over 65 with a long smoking history, your risk is meaningfully higher than average. Women at any age face lower absolute risk, but they should take blood in the urine seriously rather than assuming a benign cause.
Quitting smoking is the single most effective thing you can do to lower your risk. Staying well hydrated may also help by diluting potential carcinogens in the bladder and flushing them out more frequently, though the evidence for this is less definitive than for smoking cessation. There is no routine screening test recommended for the general population, so awareness of symptoms, particularly painless blood in the urine, remains the primary path to early detection.